Precigen (PGEN) Payables (2012 - 2026)
Precigen (PGEN) reported Payables of $2.6 million for Q1 2026, down 16.67% year-over-year from $3.1 million in Q1 2025, and down 78.4% quarter-over-quarter from $12.0 million in Q4 2025.
Precigen (PGEN) Payables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Payables data on file, last reported at $2.6 million in Q1 2026.
- Payables for Q1 2026 came in at $2.6 million, down 16.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (down 16.67% YoY), and the FY2025 annual result was $12.0 million, up 239.42% from the prior year.
- Payables retreated to $2.6 million in Q1 2026 per PGEN's latest filing, from $12.0 million in the prior quarter.
- Over five years, Payables peaked at $47.3 million in Q4 2022 and troughed at $1.7 million in Q4 2023.
- A 5-year average of $7.5 million and a median of $4.2 million in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2023: Payables soared 1419.51% in 2022, then slumped 96.35% in 2023.
- A 5-year view of Payables shows it stood at $47.3 million in 2022, then tumbled by 96.35% to $1.7 million in 2023, then jumped by 104.58% to $3.5 million in 2024, then jumped by 239.42% to $12.0 million in 2025, then sank by 78.4% to $2.6 million in 2026.
- Business Quant data shows PGEN's Payables at $2.6 million in Q1 2026, $12.0 million in Q4 2025, and $6.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 34.55 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 11.99 Mn |
| Sep 30, 2025 | 6.26 Mn |
| Jun 30, 2025 | 3.92 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 17.63 Mn |
| Dec 31, 2022 | 47.29 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 2.67 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Sep 30, 2021 | 3.62 Mn |
| Jun 30, 2021 | 4.94 Mn |